Hedge Fund - RA Capital Management
Janux Therapeutics Inc. (JANX)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $154,417,763 | 1.58% | 11,189,693 | $23.52 |
| 2 | 2025 - Q3 (2025-09-30) | $273,476,097 | 3.37% | 11,189,693 | $24.35 |
| 3 | 2025 - Q2 (2025-06-30) | $258,481,908 | 4.35% | 11,189,693 | $26.35 |
| 4 | 2025 - Q1 (2025-03-31) | $302,121,711 | 5.05% | 11,189,693 | $37.69 |
| 5 | 2024 - Q4 (2024-12-31) | $554,977,008 | 7.38% | 10,365,652 | $52.89 |
| 6 | 2024 - Q3 (2024-09-30) | $416,395,570 | 4.8% | 9,165,652 | $43.50 |
| 7 | 2024 - Q2 (2024-06-30) | $383,949,162 | 5.07% | 9,165,652 | $46.95 |
| 8 | 2024 - Q1 (2024-03-31) | $345,086,798 | 4.39% | 9,165,652 | $21.78 |
| 9 | 2023 - Q4 (2023-12-31) | $98,347,446 | 1.53% | 9,165,652 | $8.65 |
| 10 | 2023 - Q3 (2023-09-30) | $92,389,772 | 1.81% | 9,165,652 | $11.53 |
| 11 | 2023 - Q2 (2023-06-30) | $102,920,544 | 1.94% | 8,670,644 | $13.37 |
| 12 | 2023 - Q1 (2023-03-31) | $104,914,792 | 2.37% | 8,670,644 | $16.64 |
| 13 | 2022 - Q4 (2022-12-31) | $114,192,381 | 2.31% | 8,670,644 | $14.64 |
| 14 | 2022 - Q3 (2022-09-30) | $117,401,000 | 2.5% | 8,670,644 | $13.36 |
| 15 | 2022 - Q2 (2022-06-30) | $105,869,000 | 2.82% | 8,670,644 | $11.84 |
| 16 | 2022 - Q1 (2022-03-31) | $124,337,000 | 2.71% | 8,670,644 | $16.36 |
| 17 | 2021 - Q4 (2021-12-31) | $171,072,000 | 3.01% | 8,670,644 | $20.96 |
| 18 | 2021 - Q3 (2021-09-30) | $187,546,000 | 2.59% | 8,670,644 | $28.77 |
| 19 | 2021 - Q2 (2021-06-30) | $216,333,000 | 3.47% | 8,670,644 | $22.27 |
The displayed share prices are average quarterly stock market prices.